Showing 18,201 - 18,220 results of 101,525 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (teer decrease)) ))', query time: 0.98s Refine Results
  1. 18201

    Rabbit intake data. by Ashley Sum Yin U. (18437434)

    Published 2024
    “…Most rabbits in our data were adults (46.7%), non-brachycephalic (66.7%), erect-eared (82.5%), short-furred (76.2%), and subsequently adopted (80.3%). …”
  2. 18202
  3. 18203
  4. 18204
  5. 18205
  6. 18206

    Dyrk1B protein expression and turn-over in Neuro 2a cells. by Konstantinos Tsioras (490909)

    Published 2013
    “…Dyrk1B is not detectable in non-transfected Neuro 2a cells (CTL) with available antibody, while transgene Dyrk1B, obvious at 16h, is decreased overtime in a proteasome-specific manner (upper panel). …”
  7. 18207
  8. 18208

    Single-Molecule Magnets:  Structural Characterization, Magnetic Properties, and <sup>19</sup>F NMR Spectroscopy of a Mn<sub>12</sub> Family Spanning Three Oxidation Levels by Nicole E. Chakov (2638930)

    Published 2005
    “…The syntheses, crystal structures, and magnetic properties of [Mn<sub>12</sub>O<sub>12</sub>(O<sub>2</sub>CC<sub>6</sub>F<sub>5</sub>)<sub>16</sub>(H<sub>2</sub>O)<sub>4</sub>] (<b>2</b>), (NMe<sub>4</sub>)[Mn<sub>12</sub>O<sub>12</sub>(O<sub>2</sub>CC<sub>6</sub>F<sub>5</sub>)<sub>16</sub>(H<sub>2</sub>O)<sub>4</sub>] (<b>3</b>), and (NMe<sub>4</sub>)<sub>2</sub>[Mn<sub>12</sub>O<sub>12</sub>(O<sub>2</sub>CC<sub>6</sub>F<sub>5</sub>)<sub>16</sub>(H<sub>2</sub>O)<sub>4</sub>] (<b>4</b>) are reported. …”
  9. 18209
  10. 18210

    Solvent-Induced Change of Electronic Spectra and Magnetic Susceptibility of Co<sup>II</sup> Coordination Polymer with 2,4,6-Tris(4-pyridyl)-1,3,5-triazine by Ruslan A. Polunin (1593139)

    Published 2015
    “…Resolvation of <b>2</b> by ethanol or water resulted in restoration of spectral characteristics and χ<sub>M</sub> values almost to the level of that of <b>1</b>. χ<sub>M</sub><i>T</i> versus <i>T</i> curves for <b>1</b> and samples, obtained by resolvation of <b>2</b> by H<sub>2</sub>O or C<sub>2</sub>H<sub>5</sub>OH, were fitted using a model for Co<sup>II</sup> complex with zero-field splitting of this ion.…”
  11. 18211
  12. 18212

    Estimated <i>l/|v|</i> for kite thoraces, and DCMD and behavioural responses to looming discs of varying <i>l/|v|</i> in <i>Locusta migratoria</i>. by Roger D. Santer (117354)

    Published 2012
    “…D, The number of glides initiated before collision expressed as a proportion of stimulus presentations. Plot shows the combined effect of increasing glide occurrence with decreasing <i>l/|v|</i> (panel A, black circles), and increasing probability of glide initiation before collision with increasing <i>l/|v|</i> (panel C). …”
  13. 18213

    DataSheet1_Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study.pd... by Shigeru Sakurai (17805929)

    Published 2024
    “…Despite their importance, integrin and FAK expression in oral squamous cell carcinoma (OSCC) tissue and the prognosis of patients with OSCC remains elusive.</p><p>Methods: In a retrospective observational study, we immunohistochemically evaluated integrin αV, β1, β3, β5, β6, FAK, and phosphorylated-FAK (pFAK) expressions as prognostic predictors in 96 patients with OSCC. …”
  14. 18214
  15. 18215

    LTP modulates steady-state inactivation of A-type K<sup>+</sup> currents. by Sung-Cherl Jung (261358)

    Published 2009
    “…Scale bars, 200 pA, 50 ms. The A-current available for activation at −60 mV was significantly decreased only in the neurons receiving paired stimulation 10 min after conditioning stimulation (a red arrow). …”
  16. 18216
  17. 18217
  18. 18218
  19. 18219

    Image_5_YY1 Promotes Telomerase Activity and Laryngeal Squamous Cell Carcinoma Progression Through Impairment of GAS5-Mediated p53 Stability.jpeg by Xudong Wei (50612)

    Published 2021
    “…Collectively, YY1 can stimulate proliferation and telomerase activity of LSCC cells through suppression of GAS5-dependent p53 stabilization or by decreasing p53 stability via a direct interaction with p300, suggesting that YY1 presents a therapeutic target as a potential oncogene in LSCC development and progression.…”
  20. 18220

    Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis by Elizabeth S. Mearns (731188)

    Published 2015
    “…SGLT2 inhibitors, empagliflozin/linagliptin, liraglutide and sitagliptin decreased SBP (range, 1.88–5.43mmHg). No therapy increased UTI risk vs. placebo; however, SGLT2 inhibitors were associated with an increased risk of GTI (range, 2.16–8.03).…”